
Eli Lilly Reports 45% Revenue Surge Amid Profit Forecast Cut
Indianapolis, Indiana – Eli Lilly and Company (LLY) announced a 45% increase in its first-quarter 2025 revenue, reaching $12.73 billion. The surge is attributed mainly to strong sales of its weight-loss drugs Mounjaro and Zepbound. Mounjaro sales …